In particular, we found that treatment with 82 mg/kg MBP-11901 at 1T/2D, 1T/3D, and 1T/4D for 42 d caused 99.82 ± 0.33, 99.51 ± 0.81, and 99.48 ± 0.60% inhibition of tumor growth, respectively, compared with the saline-treated control (Figure 5C and Figure S5B and Table 4), whereas, treatment with 164 mg/kg Nexavar® at 1T/1D and 1T/2D for 42 d caused 85.68 ± 13.60 and 88.02 ± 4.53% inhibition of tumor growth, respectively, compared with the saline-treated control (Figure 5C and Figure S5B and Table 4). This evidence concerns the gene MBP and neoplasm.